Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 23, 2018
[Construction and in vitro verification of a new humanized anti-CD19 CAR-T cells with high affinity]
C X Zhang, H Cheng, X Han, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 14, 2025
[The role of AKT inhibitors combined with Ruxolitinib in ameliorating myeloproliferative disorders in mice with CALR gene mutations]
L W Zhang, Q G Zhang, M C Ji, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 28, 2023
[Long-term safety and activity of humanized CD19 chimeric antigen receptor T cells for children and young adults with relapsed/refractory acute lymphoblastic leukemia]
S Y Wang, L N Zhao, H Cheng, et al.
Zhonghua Yi Xue Za Zhi
|
August 21, 2024
[The occurrence of cytokine release syndrome and its impact on the prognosis of patients with relapsed and refractory multiple myeloma following chimeric antigen receptor T-cell therapy]
L Nian, X X Jie, L W Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
June 18, 2019
[Clinical analysis of disseminated intravascular coagulation in 6 patients with hematological diseases after CAR-T treatment]
K M Qi, J Cao, H Cheng, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 13, 2021
[Influence of prognostic nutritional index and controlling nutritional status on the prognosis of patients with multiple myeloma]
F Liang, X Y Dong, G F Tang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
December 4, 2023
[Observation of liver indexes in patients with relapsed/refractory multiple myeloma treated with CAR-T-cells based on BCMA]
Q Sun, Y K Qi, K M Qi, et al.
Zhonghua Nei Ke Za Zhi
|
June 3, 2024
[Impact of autologous hematopoietic stem cell transplantation on the efficacy of CAR-T treatment of relapsed/refractory multiple myeloma]
M J Ding, X X Jie, H J Li, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 23, 2018
[Construction and in vitro verification of a new humanized anti-CD19 CAR-T cells with high affinity]
C X Zhang, H Cheng, X Han, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
October 14, 2025
[The role of AKT inhibitors combined with Ruxolitinib in ameliorating myeloproliferative disorders in mice with CALR gene mutations]
L W Zhang, Q G Zhang, M C Ji, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 28, 2023
[Long-term safety and activity of humanized CD19 chimeric antigen receptor T cells for children and young adults with relapsed/refractory acute lymphoblastic leukemia]
S Y Wang, L N Zhao, H Cheng, et al.
Zhonghua Yi Xue Za Zhi
|
August 21, 2024
[The occurrence of cytokine release syndrome and its impact on the prognosis of patients with relapsed and refractory multiple myeloma following chimeric antigen receptor T-cell therapy]
L Nian, X X Jie, L W Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
June 18, 2019
[Clinical analysis of disseminated intravascular coagulation in 6 patients with hematological diseases after CAR-T treatment]
K M Qi, J Cao, H Cheng, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 13, 2021
[Influence of prognostic nutritional index and controlling nutritional status on the prognosis of patients with multiple myeloma]
F Liang, X Y Dong, G F Tang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
December 4, 2023
[Observation of liver indexes in patients with relapsed/refractory multiple myeloma treated with CAR-T-cells based on BCMA]
Q Sun, Y K Qi, K M Qi, et al.
Zhonghua Nei Ke Za Zhi
|
June 3, 2024
[Impact of autologous hematopoietic stem cell transplantation on the efficacy of CAR-T treatment of relapsed/refractory multiple myeloma]
M J Ding, X X Jie, H J Li, et al.
Page
of 2